Allied Market Research published a report titled “Global
Bio-implants Market (Types, and geography) - Size, Share, Global Trends,
Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities,
Segmentation and Forecast, 2013 – 2020.” The report provides in-depth analysis
of the global bio-implants market.
The report offers precise study of the key factors
influencing the market growth in numerous geographies. The report comprises
extensive information in the form of statistics and figures, which would assist
the global investors and market participants to know the competitive landscape
along with growth prospects of the bio-implants market in different
geographical regions.
Cardiovascular implants are rocketing the growth of global bio-implants market. Rising cases of cardiac resynchronization have increased
the need of pacing devices. “Technological advancement in ventricular assist
devices, implantable monitors and heart valves would encourage the use of
structural implants,” states AMR analyst.
Some of the key players with cardiac implants devices such
as cardiac stents, pacing devices, and structural cardiac implants are Boston
Scientific, Medtronic, Johnson & Johnson and St.Jude Medical. As per the
report, cardiovascular diseases would become a leading cause of both disability
and death globally.
“Cardiovascular diseases result into disturbance in heart functioning.
Symptoms can be alleviated through medication and the root cause can be treated
by repairing injured tissues. Wide varieties of biomaterials are used in the
repair and replacement of impaired heart tissues. Cardiovascular biomaterials
include metals, polymers, and processed biological substances. Metals such as
stainless steel, cobalt-chrome alloys and titanium based alloys are used in
cardiovascular applications such as endovascular stents, heart valves and
stent-graft combinations,” said Roshan Deshmuk, AMR analyst.
